Auricular Acupuncture vs SOC in Migraine HA (MigAcu)

University of Louisville (UOFL) logo

University of Louisville (UOFL)

Status

Enrolling

Conditions

Migraine Headache

Treatments

Other: Auricular Acupuncture
Drug: Metoclopramide 0.1 mg/kg, max 10mg
Drug: Normal saline fluid bolus 20mL/kg, max 1000mL
Drug: Ketorolac 0.5mg/kg, max 30mg
Drug: Diphenhydramine 1mg/kg, max 50mg

Study type

Interventional

Funder types

Other

Identifiers

NCT02681211
15.0827

Details and patient eligibility

About

Patients with migraine headache will be offered the opportunity to participate in this randomized study evaluating auricular acupuncture versus standard treatment for migraine headaches for patients in the pediatric emergency department (ED).

Full description

Potential subjects will be identified using the diagnosis of migraine headache classified by the modified ICHD-II (International Classification for Headache Disorders) criteria proposed by Hershey et. al. This diagnosis will be confirmed by the investigators prior to enrollment of the subject and will be documented in the study documents. Subjects will be recruited during the scheduled work or research hours of the investigators in the ED. Eligible patients will be informed of the study including a discussion of the two possible interventions. After informed consent and assent are obtained, patients will be randomly assigned 1 of the 2 arms of the study. The target is 40 subjects in each arm. Subjects will be assigned to a study group using a computer generated randomization schema. This randomization will only be known to one unblinded collaborator that will not be enrolling subjects or be involved in the data analysis. If assigned to receive intravenous migraine medications the subject will be treated with the standard of care medications which include ketorolac (0.5mg/kg, max 30mg), metoclopramide (0.1 mg/kg, max 10mg), diphenhydramine (1mg/kg, max 50mg) plus a normal saline fluid bolus (20mL/kg, max 1000mL). If assigned to the auricular acupuncture arm, efficacious ear points will be located by a needle contact test and/or an electrical point finder which emits an acoustic alarm when a change in electrical resistance is detected signifying a potential active auricular acupoint. If the subject does not improve with acupuncture, they will be assessed by the ED physician and at the MD discretion further emergency department treatment will be administered which may include intravenous migraine medications as this is the current standard of care in the Norton Children's Hospital/Norton Children's Medical Center (KCH/KCMC) ED. All subjects will be contacted 2 to 6 days after discharge to determine their clinical status. If the darts are still in place at the follow-up call, the subjects will be contacted at 2 weeks and weekly thereafter until all darts have fallen out.

Enrollment

80 estimated patients

Sex

All

Ages

8 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Confirmation of the diagnosis of migraine headache

Exclusion criteria

  • Patients who received ED migraine medications (including ibuprofen or other NSAIDS) prior to study evaluation.
  • Allergy to any of the medications used in our migraine regimen protocol.
  • Patients exhibiting focal clinical neurological exam findings that the investigator deems makes the patient not a good candidate for this study.
  • Patients with underlying abnormal brain pathology (e.g. mass or bleed) as the potential cause of the migraine

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

80 participants in 2 patient groups

Auricular Acupuncture
Experimental group
Description:
If assigned to the auricular acupuncture arm, efficacious ear points will be located by a needle contact test and/or an electrical point finder which emits an acoustic alarm when a change in electrical resistance is detected signifying a potential active auricular acupoint.
Treatment:
Other: Auricular Acupuncture
Medication and Fluid
Active Comparator group
Description:
If assigned to receive intravenous medications and fluid the subject will be treated with the ED standard of care medications which include: Ketorolac 0.5mg/kg, max 30mg Metoclopramide 0.1 mg/kg, max 10mg Diphenhydramine 1mg/kg, max 50mg Normal saline fluid bolus 20mL/kg, max 1000mL
Treatment:
Drug: Diphenhydramine 1mg/kg, max 50mg
Drug: Ketorolac 0.5mg/kg, max 30mg
Drug: Normal saline fluid bolus 20mL/kg, max 1000mL
Drug: Metoclopramide 0.1 mg/kg, max 10mg

Trial contacts and locations

2

Loading...

Central trial contact

Danielle Graff, MD; Mark J McDonald, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems